THE INFLUENCE OF GENOMICS ON PERSONALIZED MEDICINE AND PUBLIC HEALTH POLICIES
Main Article Content
Keywords
personalized medicine, public health policy, Genome-Wide Association Studies, Polygenic Risk Scores, genetic data, data privacy
Abstract
With genomics, precise healthcare interventions resulting from genetic profiles enable revolutionizing personalized medicine as well as public health policy. This study explores how genomic data can affect healthcare by examining the associations between genetic variants and major health conditions such as cardiovascular disease, type 2 diabetes, and lung cancer. Using a mixed methods approach, the study combines a systematic review of existing literature, analysis of data from reputable genomic databases, and case studies to ground genomics in healthcare. Population Specific Genetic Markers were identified using Genome Wide Association Studies (GWAS) and Polygenic Risk Scores (PRS) and significant associations were found that highlight the predictive power of genomics in the prevention and treatment of disease. Results show that increased likelihood of policy adoption is associated with high PRS values, implying that genomic insights can be used to target public health interventions. Specifically, ethical considerations of data privacy, patient consent and equitable access were considered as genomics was integrated into public health methods, with the call to integrate responsibly. The present study provides novel insights by linking PRS to the adoption of public health policy and demonstrating the potential for genomics to facilitate both personalized healthcare and equitable public health policy. Future research should be directed to expanding genetic databases regarding populations which can be underrepresented and refining algorithms that incorporate lifestyle factors to improve predictive accuracy.
References
2. Brand, A. (2012). Public health genomics and personalized healthcare: a pipeline from cell to society. Drug Metabolism and Drug Interactions, 27(3), 121-123.
3. Burke, W., Burton, H., Hall, A. E., Karmali, M., Khoury, M. J., Knoppers, B., ... & Zimmern, R. L. (2010). Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine? Genetics in Medicine, 12(12), 785-791.
4. Burke, W., Khoury, M. J., Stewart, A., & Zimmern, R. L. (2006). The path from genome-based research to population health: development of an international public health genomics network. Genetics in Medicine, 8(7), 451-458.
5. Creswell, J. W., & Clark, V. L. P. (2017). Designing and conducting mixed methods research. Sage publications.
6. Farmer, Y., & Godard, B. (2007). Public health genomics (PHG): from scientific considerations to ethical integration. Genomics, Society and Policy, 3(3), 14.
7. Franzago, M., Santurbano, D., Vitacolonna, E., & Stuppia, L. (2020). Genes and diet in the prevention of chronic diseases in future generations. International journal of molecular sciences, 21(7), 2633.
8. Galasso, I. (2019). Precision medicine in society: Promises, expectations and concerns around social and health equity.
9. Geller, G., Dvoskin, R., Thio, C. L., Duggal, P., Lewis, M. H., Bailey, T. C., ... & Kahn, J. P. (2014). Genomics and infectious disease: a call to identify the ethical, legal and social implications for public health and clinical practice. Genome medicine, 6, 1-13.
10. Ginsburg, G. S., & Phillips, K. A. (2018). Precision medicine: from science to value. Health affairs, 37(5), 694-701.
11. Hall, W. D., Morley, K. I., & Lucke, J. C. (2004). The prediction of disease risk in genomic medicine: Scientific prospects and implications for public policy and ethics. EMBO reports, 5(S1), S22-S26.
12. Khoury, M. J., Bowen, M. S., Clyne, M., Dotson, W. D., Gwinn, M. L., Green, R. F., ... & Yu, W. (2018). From public health genomics to precision public health: a 20-year journey. Genetics in Medicine, 20(6), 574-582.
13. Offit, K. (2011). Personalized medicine: new genomics, old lessons. Human genetics, 130, 3-14.
14. Prasher, B., Gibson, G., & Mukerji, M. (2016). Genomic insights into ayurvedic and western approaches to personalized medicine. Journal of genetics, 95, 209-228.
15. Quaak, M., Van Schayck, C. P., Knaapen, A. M., & Van Schooten, F. J. (2009). Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?. European Respiratory Journal, 33(3), 468-480.
16. Wilkinson, M. D., Dumontier, M., Aalbersberg, I. J., Appleton, G., Axton, M., Baak, A., ... & Mons, B. (2016). The FAIR Guiding Principles for scientific data management and stewardship. Scientific data, 3(1), 1-9.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Dr Ashwini L H
Ex-Assistant Professor, JJM Medical College and rc Davanagere, Karnataka
Dr Vinaykumar L H
Administrative Medical Officer Phc Aladageri Hirekerur tq, Haveri District
Dr Hanumanaik L
Chief Medical Officer GH Harihara, Harihara tq, Davanagere District